Aurobindo Pharma
AUROPHARMA.NS
#1804
Rank
S$12.28 B
Marketcap
$21.15
Share price
-3.17%
Change (1 day)
49.02%
Change (1 year)

Earnings for Aurobindo Pharma (AUROPHARMA.NS)

Earnings in 2024 (TTM): S$0.84 Billion

According to Aurobindo Pharma 's latest financial reports the company's current earnings are S$3.52 Billion. In 2023 the company made an earning of S$0.65 Billion, an increase over its 2022 earnings that were of S$0.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurobindo Pharma from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.84 B28.28%
2023 S$0.65 B55.34%
2022 S$0.42 B-38.78%
2021 S$0.69 B-47.85%
2020 S$1.32 B92.99%
2019 S$0.68 B17.55%
2018 S$0.58 B-13.37%
2017 S$0.67 B5.61%
2016 S$0.63 B19.84%
2015 S$0.53 B4.56%
2014 S$0.50 B112.18%
2013 S$0.24 B91.27%
2012 S$0.12 B